UK markets closed

China Jo-Jo Drugstores, Inc. (CJJD)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.9889+0.2189 (+7.90%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.52M
Enterprise value 23.88M
Trailing P/E 69.00
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.01
Price/book (mrq)0.29
Enterprise value/revenue 0.15
Enterprise value/EBITDA -166.79

Trading information

Stock price history

Beta (5Y monthly) 0.05
52-week change 3-83.00%
S&P500 52-week change 326.36%
52-week high 316.0000
52-week low 31.9500
50-day moving average 32.8822
200-day moving average 34.1680

Share statistics

Avg vol (3-month) 370.12k
Avg vol (10-day) 38.7k
Shares outstanding 52.16M
Implied shares outstanding 62.16M
Float 81.39M
% held by insiders 111.33%
% held by institutions 10.52%
Shares short (30 Apr 2024) 418.43k
Short ratio (30 Apr 2024) 41.92
Short % of float (30 Apr 2024) 40.88%
Short % of shares outstanding (30 Apr 2024) 40.85%
Shares short (prior month 15 Feb 2024) 413.47k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 301 Mar 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin -13.88%
Operating margin (ttm)0.33%

Management effectiveness

Return on assets (ttm)-12.35%
Return on equity (ttm)-108.78%

Income statement

Revenue (ttm)154.66M
Revenue per share (ttm)155.54
Quarterly revenue growth (yoy)8.00%
Gross profit (ttm)N/A
EBITDA -19.04M
Net income avi to common (ttm)-21.47M
Diluted EPS (ttm)-4.4000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.65M
Total cash per share (mrq)11.08
Total debt (mrq)37.01M
Total debt/equity (mrq)211.04%
Current ratio (mrq)1.00
Book value per share (mrq)11.22

Cash flow statement

Operating cash flow (ttm)-3.62M
Levered free cash flow (ttm)5.19M